Shots:
- Coloplast to acquire Atos Medical for an enterprise value of $2.49B from PAI Partners. The transaction is expected to close in Q2’22
- Coloplast obtains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure that also supports its offerings in urology, continence and wound care
- Additionally, the combined entity will generate operational synergies by utilizing Coloplast infrastructure. Atos Medical focusses to improve the lives of patients from both laryngectomy and tracheostomy procedures
Click here to read the full press release/ article | Ref: Globe Newswire | Image: Logodix
The post Coloplast to Acquire Atos Medical for ~$2.49B first appeared on PharmaShots.
